Consensus conference. Clinical use of botulinum toxin. National Institutes of Health.
D001764:Blepharospasm / Q000188:drug therapy; D001905:Botulinum Toxins / Q000494:pharmacology / Q000627:therapeutic use*; D000075202:Contraindications; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy; D009469:Neuromuscular Junction; D013064:Speech Disorders / Q000188:drug therapy; D013285:Strabismus / Q000188:drug therapy; D014832:Voice Disorders / Q000188:drug therapy
D001905:Botulinum Toxins